Brief: Amplia Therapeutics Posts HY Loss Attributable A$4.1 Million
Nov 27 (Reuters) - Amplia Therapeutics Ltd ATX.AX: HY LOSS ATTRIBUTABLE A$4.1 MILLION HY REVENUES FROM ORDINARY ACTIVITIES & OTHER INCOME A$2.8 MILLION Further company coverage: ATX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement